Human IFN gamma ELISpot Pair

Contact us
Diaclone
Product Code: 869.060.010
Product Group: Antibody Pairs
Supplier: Diaclone
CodeSizePrice
869.060.01010 x 96£730.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Antibody Isotype: n/a
Antibody Clone: n/a
Regulatory Status: RUO
Target Species: Human
Application: ELISpot

Documents

Further Information

Antigen Synonyms:
IFN-g, IFN-gamma
Cross reaction:
No cross reactivity with other human cytokines. Cross reactivity with simian IFN-g.
Description:
Diaclone ELISpot matched antibody pairs are extensively validated and include pre-titrated capture antibody and biotinylated detection antibody. Antibodies are supplied in quantities sufficient for 10 x 96 samples.
Detection Target:
IFN gamma
Reactivity:
Human
Research Area:
Cytokines / Growth Factors
Specificity:
Recognizes natural human IFN-g

References

  1. Andres, C. et al., J. Virol.,2015;89(18): 9189-9199. HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses. https://www.ncbi.nlm.nih.gov/pubmed/26109727
  2. Bricaire, F. et al., Bull Acad Natl Med.,2006;190(4-5):1035-46; discussion 1046-9. Evaluation of residual immune response against human pox virus before and after revaccination in healthy volunteers. https://www.ncbi.nlm.nih.gov/pubmed/17195626
  3. Carcelain G. et al., J. Virol., 2001; 75(1) : 234 - 241. Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection. https://www.ncbi.nlm.nih.gov/pubmed/11119593
  4. Frange, P. et al., Front Immunol. 2021; 12: 662894. . Impact of Early Versus Late Antiretroviral Treatment Initiation on Naive T Lymphocytes in HIV-1-Infected Children and Adolescents ? The-ANRS-EP59-CLEAC Study. https://pubmed.ncbi.nlm.nih.gov/33968064/
  5. Garc?a, F. et al., Science Translational Medicine, 2013;5:166ra2. A Dendritic Cell-Based Vaccine Elicits T Cell Responses Associated with Control of HIV-1 Replication. https://www.ncbi.nlm.nih.gov/pubmed/23283367
  6. Garcia, F. et al.,The Journal of Infectious Disease,2011; 203(4): 473-478. A Therapeutic Dendritic Cell-Based Vaccine for HIV-1 Infection. https://www.ncbi.nlm.nih.gov/pubmed/21233310
  7. Guihot, A. et al., Blood,2007; 111:1387-1395. Multicentric Castleman disease is associated with polyfunctional effector memory HHV-8-specific CD8+ T cells. https://www.ncbi.nlm.nih.gov/pubmed/18000163
  8. Guihot, A. et al., J Infect Dis.,2006;194(8):1078-88. Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma. https://www.ncbi.nlm.nih.gov/pubmed/16991082
  9. Mohty M. et al., Bone Marrow Transplant., 2004;33(8): 839-846. Cytomegalovirus-specific immune recovery following allogeneic HLA-identical sibling transplantation with reduced-intensity preparative regimen. https://www.ncbi.nlm.nih.gov/pubmed/14767500
  10. Nakid-Cordero, C. et al., PLoS One. 2019 Oct 22;14(10):e0224211.. Skewed T cell responses to Epstein-Barr virus in long-term asymptomatic kidney transplant recipients.. https://www.ncbi.nlm.nih.gov/pubmed/31639143
  11. Samri A. et al., J. Virol., 2000; 74(19): 9306 - 9312. Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cells. https://www.ncbi.nlm.nih.gov/pubmed/10982378
  12. Scarpellini P. et al. J. Clin. Microbiol., 2004; 42(8): 3469 - 3474. Selected Pool of Peptides from ESAT-6 and CFP-10 Proteins for Detection of Mycobacterium tuberculosis Infection. https://www.ncbi.nlm.nih.gov/pubmed/15297485
  13. Scholzen, A. et al., Front Immunol. 2019 Feb 15;10:207.. Promiscuous Coxiella burnetii CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine.. https://www.ncbi.nlm.nih.gov/pubmed/30828331
  14. Speiser D.E. et al., J. Clin. Invest., 2005; 115(3): 739 - 746. Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909. https://www.ncbi.nlm.nih.gov/pubmed/15696196
  15. Speiser, D. E. et al., PNAS,2008; 105(10): 3849-3854.. Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigen. https://www.ncbi.nlm.nih.gov/pubmed/18319339